Evidence map›Paper›PMID 32629771›Full record

ArticleBiomedicines2020

It Takes Two: Dimerization Is Essential for the Broad-Spectrum Predatory and Defensive Activities of the Venom Peptide Mp1a from the Jack Jumper Ant

Samantha A Nixon, Zoltan Dekan, Samuel D Robinson, Shaodong Guo, Irina Vetter, Andrew C Kotze, Paul F Alewood, Glenn F King, Volker Herzig

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Animal Venoms-Curse or Cure?Biomedicines · 2021
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Samantha A NixonInstitute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
Zoltan DekanInstitute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
Samuel D RobinsonInstitute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
Shaodong GuoInstitute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
Irina VetterInstitute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
Andrew C KotzeCSIRO Agriculture and Food, St Lucia, QLD 4072, Australia.
Paul F AlewoodInstitute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
Glenn F KingInstitute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
Volker HerzigInstitute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
The University of Queensland · AUCommonwealth Scientific and Industrial Research Organisation · AU

Funding

Australian Research Council DP190103787Australian Research Council FT190100482National Health and Medical Research Council AP1072113National Health and Medical Research Council APP1136889Westpac Bicentennial Foundation Westpac Future Leaders Scholarship
6 · The paper itself

Abstract

Ant venoms have recently attracted increased attention due to their chemical complexity, novel molecular frameworks, and diverse biological activities. The heterodimeric peptide ∆-myrtoxin-Mp1a (Mp1a) from the venom of the Australian jack jumper ant,

Indexed as

antantimicrobialantiparasiticheterodimerpilosulinvenomvenom peptide

Identifiers

PMID32629771
PMCPMC7400207
OpenAlexW3037000233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.